MiR-1 mediated suppression of Sorcin regulates myocardial contractility through modulation of Ca 2+ signaling

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 5, 2012, Pages 1027-1037

  Ali, Rahmat ^a   Huang, Yan ^a   Maher, Stephen E ^a   Kim, Richard W ^b   Giordano, Frank J ^a,c   Tellides, George ^a,d   Geirsson, Arnar ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c YALE UNIVERSITY   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Calcium signaling; Dicer; Heart failure; MicroRNA; Myocardial contractile function

Indexed keywords

CALCIUM ION; DICER; LUCIFERASE; MICRORNA; MICRORNA 1; SMALL INTERFERING RNA; SORCIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; EXCITATION CONTRACTION COUPLING; GENE FUNCTION; GENE SILENCING; GENETIC REGULATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TARGETING; RNA INTERFERENCE; UPREGULATION; WILD TYPE;

ANIMALS; BASE SEQUENCE; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CARDIAC VOLUME; CARDIOMYOPATHIES; CELL LINE; DEAD-BOX RNA HELICASES; HEART; HUMANS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MYOCARDIAL CONTRACTION; MYOCARDIUM; RIBONUCLEASE III; RNA INTERFERENCE; RNA, SMALL INTERFERING; UP-REGULATION;

MUS;

EID: 84862801651     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.01.020     Document Type: Article

References (37)

1. Jessup M., Brozena S. Heart failure. N Engl J Med 2003, 348:2007-2018.
2. Chien K. Stress pathways and heart failure. Cell 1999, 98:555-558.
3. Hoshijima M., Chien K. Mixed signals in heart failure: cancer rules. J Clin Invest 2002, 109:849-855.
4. Bartel D. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Rooij E., Marshall W.S., Olson E. Toward microRNA-based therapeutics for heart disease. The sense in antisense. Circ Res 2008, 103:919-928.
6. Bernstein E., Caudy A.A., Hammond S.M., Hannon G.J. Role for a bidentate ribonuclease in the initation step of RNA interference. Nature 2001, 409:363-366.
7. Chen J.-F., Murchison E.P., Tang R., Callis T.E., Tatsuguchi M., Deng Z., et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A 2008, 105:2111-2116.
8. Zhao Y., Ransom J., Li A., Vedantham V., Drehle M., Muth A., et al. Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2. Cell 2007, 129:303-317.
9. Martins PAdC, Bourajjaj M., Gladka M., Kortland M., Oort RJv, Pinto Y.M. Conditional Dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 2008, 118:1567-1576.
10. Gregory R.I. Yan K-o, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, et al. The microprocessor complex mediated the genesis of microRNAs. Nature 2004, 432:235-240.
11. Rao P.K., Toyama Y., Chiang H.R., Gupta S., Bauer M., Medvid R., et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 2009, 105:585-594.
12. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., et al. HL-1 cells: A cardiac muscle cell line that contracts and retains pheontypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998, 95:2979-2984.
13. White S.M., Constantin P.E., Claycomb W.C. Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 2004, 286:H823-H829.
14. Sohal D., Nghiem M., Crackower M., Witt S., Kimball T., Tymitz K., et al. Temporally regulated and tissue-specific gene manipulation in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 2001, 89:20-25.
15. Luo X., Xiao J., Lin H., Li B., Lu Y., Yang B., et al. Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding Genes and potential implications in regional heterogeneity of their expressions. J Cell Physiol 2007, 212:358-367.
16. Terentyev D., Balevych A.A., Terentyeva R., Martin M.M., Malana G.E., Kuhn D.E., et al. miR-1 overexpression enhances Ca2+ release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56α and causing CaMHII-dependent hyperphosphorylation of RyR2. Circ Res 2009, 104:514-521.
17. Meyers M.B., Fischer A., Sun Y.-J., Lopes C.M.B., Rohacs T., Nakamura T.Y., et al. Sorcin regulates excitation-contraction coupling in the heart. J Biol Chem 2003, 278:28865-28871.
18. Watanabe H., Saito H., Rychahou P.G., Uchida T., Evers B.M. Aging is associated with decreased pancreatic acinar cell regeneration and phosphatidylinositol 3-kinase/Akt activation. Gastroenterology 2005, 128:1391-1404.
19. Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M., et al. Therapeutic silencing of an endogenous gene by systematic administration of modified siRNA. Nature 2004, 432:173-178.
20. Ikeda S., He A., Kong S.W., Lu J., Bejar R., Bodyak N., et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol 2009, 29:2193-2204.
21. Zhao Y., Samal E., Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436:214-220.
22. Chen J.-F., Mandel E., Thomson J., Wu Q., Callis T., Hammond S., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006, 38:228-233.
23. Elia L., Contu R., Quintavalle M., Varrone F., Chimenti C., Russo M.A., et al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 2009, 120:2377-2385.
24. Kwon C., Han Z., Olson E., Srivastava D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc Natl Acad Sci U S A 2005, 102:18986-18991.
25. Yang B., Lin H., Ziao J., Lu Y., Luo X., Li B., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13:486-491.
26. Farrell E.F., Antaramian A., Rueda A., Gomez A.M., Valdivia H.H. Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. J Biol Chem 2003, 278:34660-34666.
27. Meyers M.B., Pickel V.M., Sheu S.-S., Sharma V.K., Scotto K.W., Fishman G.I. Association of Sorcin with the cardiac ryanodine receptor. J Biol Chem 1995, 270:26411-26418.
28. Seidler T., Miller S.L., Loughrey C.M., Kania A., Burow A., Kettlewell S., et al. Effects of adenovirus-mediated sorcin overexpression on excitation-contraction coupling in isolated rabbit cardiomyocytes. Circ Res 2003, 93:132-139.
29. Fowler M.R., Colotti G., Chiancone E., Higuchi Y., Seidler T., Smith G.L. Complex modulation of L-type Ca2+ current inactivation by sorcine in isolated rabbit cardiomyocytes. Eur J Physiol 2009, 457:1049-1060.
30. Anthony D.F., Beattie J., Paul A., Currie S. Interaction of calcium/calmodulin-dependent protein kinase IIdc with corcin indirectly modulates ryanodine receptor function in cardiac myocytes. J Mol Cell Cardiol 2007, 43:492-503.
31. George C.H., Rogers S.A., Bertrand B.M.A., Tunwell R.E.A., Thomas N.L., Steele D.S., et al. Alernative spicing of ryanodine receptors modulates cardiomyocyte Ca2+ signalining and susceptibility to apoptosis. Circ Res 2007, 100:874-887.
32. Lompre A.-M., Hajjar R.J., Harding S.E., Kranias E.G., Lohse M.J., Marks A.R. Ca2+ cycling and new therapeutic approaches for heart failure. Circulation 2010, 121:822-830.
33. Brinks H., Rohde D., Voelkers M., Qiu G., Pleger S.T., Herzog N., et al. S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes. J Am Coll Cardiol 2011, 58:966-973.
34. Thum T., Galuppo P., Wolf C., Fiedler J., Kneitz S., van Laake L., et al. MicroRNAs in the human heart. A clue to fetal gene reprogramming in heart failure. Circulation 2007, 116:258-267.
35. Matkovich S.J., Youker D.J.V.B.A., Torre-Amione G., Diwan A., Eschenbacher W.H., Dorn L.E., et al. Reciprocal regulation of myocardial mircoRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009, 119:1263-1271.
36. Prasad S.V.N., Duan Z.-H., Gupta M.K., Surampudi V.S.K., Volinia S., Calin G.A., et al. Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 2009, 284:27487-27499.
37. Sucharov C., Bristow M.R., Port J.D. miRNA expression in the failing human heart: Functional correlates. J Mol Cell Cardiol 2008, 45:185-192.